Dublin, Nov. 18, 2016 -- Research and Markets has announced the addition of the "Urology Devices Market by Product and by Disease - Global Forecast to 2021" report to their offering.
The urology devices market is expected to reach USD 40.13 billion by 2021 from USD 28.35 billion in 2016, at a CAGR of 7.2%.
The urology devices market, by product, is segmented into urology endoscopes, endovision systems, robotic systems, peripheral instruments, consumables and accessories, lasers and lithotripsy devices, dialysis devices, and urodynamic systems. The dialysis devices segment is expected to account for the largest share in 2016. The large share of this segment can be attributed to the high cost of hemodialysis machines and large & regular demand for dialysis consumables.
The urology devices market, by disease type, is segmented into kidney diseases, urinary stones, benign prostatic hyperplasia, urinary incontinence, pelvic organ prolapse, urological cancer, and other diseases. The kidney disease segment is expected to account for the largest share of the global urology devices market in 2016. The rapidly growing geriatric population and rising prevalence of kidney diseases are the key factors propelling the growth of this market.
Geographically, the urology devices market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). However, Asia is projected to grow at the highest CAGR during the forecast period. Growth in the Asia is primarily driven by the rising prevalence of kidney diseases, growing geriatric population, and increasing healthcare expenditure.
The key players in the urology devices market include Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (U.S.), Olympus Corporation (Japan), KARL STORZ GmbH & Co. KG (Germany), and Richard WOLF GmbH (Germany).
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Global Urology Devices Market, By Product
7 Global Urology Devices Market, By Disease Type
8 Global Urology Devices Market, By Region
9 Competitive Landscape
10 Company Profiles
- Baxter International Inc.
- Cook Medical Incorporated
- Dornier Medtech GmbH
- Fresenius Medical Care AG & Co. KGaA
- Intuitive Surgical, Inc.
- Karl Storz GmbH & Co. Kg
- Medtronic PLC
- Olympus Corporation
- Richard Wolf GmbH
- Stryker Corporation
For more information about this report visit http://www.researchandmarkets.com/research/dgjxz9/urology_devices
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Medical Devices


L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Winter Storm Devin Triggers Massive Flight Cancellations and Travel Disruptions Across the U.S.
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock 



